It is a marker for terminally exhausted CD8+ T cells in patients with chronic hepatitis C virus and human immunodeficiency virus infections (24), and for exhaustion in tumor-infiltrating CD8+ T cells in melanoma and breast cancer (25). The gene discussed is CD8A; the disease is breast carcinoma.